Mobile

In-vivo deposition measurement of formoterol and beclomethasone after inhalation of a single dose of the combination Formoterol plus BDP HFA pMDI (Foster®, Chiesi) in healthy volunteers, asthmatic an...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-005557-30

In-vivo deposition measurement of formoterol and beclomethasone after inhalation of a single dose of the combination Formoterol plus BDP HFA pMDI (Foster®, Chiesi) in healthy volunteers, asthmatic and COPD patients

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The aim of the study is to assess intrapulmonary deposition of Foster.

Critère d'inclusion

  • The study is focused on asthma bronchiale and chronic obstructive pulmonary disease (COPD)

Liens